0.882
price down icon0.10%   -0.0021
 
loading
전일 마감가:
$0.8799
열려 있는:
$0.85
하루 거래량:
1.86M
Relative Volume:
0.30
시가총액:
$28.83M
수익:
-
순이익/손실:
$-563.30K
주가수익비율:
-4.4188
EPS:
-0.1996
순현금흐름:
$-22.23M
1주 성능:
+86.98%
1개월 성능:
+81.24%
6개월 성능:
-1.66%
1년 성능:
-58.04%
1일 변동 폭
Value
$0.8306
$0.92
1주일 범위
Value
$0.4384
$1.59
52주 변동 폭
Value
$0.38
$2.05

Promis Neurosciences Inc Stock (PMN) Company Profile

Name
명칭
Promis Neurosciences Inc
Name
전화
416-847-6898
Name
주소
SUITE 200, 1920 YONGE STREET, TORONTO
Name
직원
8
Name
트위터
Name
다음 수익 날짜
2025-03-31
Name
최신 SEC 제출 서류
Name
PMN's Discussions on Twitter

PMN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PMN
Promis Neurosciences Inc
0.882 26.80M 0 -563.30K -22.23M -0.1996
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
475.04 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
571.27 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.48 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
587.90 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.84 31.99B 3.81B -644.79M -669.77M -6.24

Promis Neurosciences Inc 주식(PMN)의 최신 뉴스

pulisher
Jul 23, 2025

ProMIS Neurosciences Gains FDA Fast Track for PMN310 - The Globe and Mail

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about ProMIS Neurosciences Inc. stockExceptional market positioning - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Is ProMIS Neurosciences Inc. a good long term investmentHigh-yield market plays - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Still undervalued? ProMIS Neurosciences keeps $9.50 target price at Leede - Cantech Letter

Jul 22, 2025
pulisher
Jul 22, 2025

Earnings Misses And Clinical Hurdles Rattle Major Stocks - Finimize

Jul 22, 2025
pulisher
Jul 22, 2025

Alzheimer’s stock triples after FDA Fast-Track Designation - MSN

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences Plunges 24.56% Intraday—Is the FDA Fast Track Outpacing Investor Sentiment? - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences Plunges 28% Intraday—Is This the Catalyst No One Saw Coming? - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

What makes ProMIS Neurosciences Inc. stock price move sharplyBreakout Level Watch - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Buy Rating for ProMIS Neurosciences Driven by Fast Track Designation and Promising Alzheimer’s Treatment Potential - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences Announces Private Placement Financing - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

What drives ProMIS Neurosciences Inc. stock priceFree Stock Index Interpretation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences announces $0.8M registered direct offering - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences announces private placement financing - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences stock gets FDA Fast Track designation for PMN310 - Investing.com

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences (PMN) Secures Funding to Enhance Therapeuti - GuruFocus

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences Announces $0.8 Million Registered Direct Offering, Priced At-the-Market Under Nasdaq Rules - The Manila Times

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences Announces Private Placement Financing | PMN Stock News - GuruFocus

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences Announces $2.4 Million PIPE Financing for Clinical Development of PMN310 - Nasdaq

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences Drops 9.82% Amid ICICI Bank's Strong Earnings - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Secures $9.2M Funding Boost: Accelerates Novel Alzheimer's Treatment Development - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

Alzheimer's Treatment Pioneer ProMIS Secures New Funding to Accelerate PMN310 Clinical Trials - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences ends at-the-market agreement and receives FDA fast track for PMN310 - Investing.com Australia

Jul 22, 2025
pulisher
Jul 22, 2025

3 Penny Stocks to Watch Now, 7/22/25 - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences Inc. Stock Analysis and ForecastFree AI-Backed Trading Signals - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences Inc Inc. (PMN) Price Performance: The Role of Supply and Demand - investchronicle.com

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences shares surge 149.77% intraday after FDA grants Fast Track designation to PMN310 for Alzheimer’s treatment. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Shares Of Micro Cap Biotech Surge After Breakthrough FDA Designation - The Globe and Mail

Jul 21, 2025
pulisher
Jul 21, 2025

Alzheimer’s stock triples after FDA Fast-Track Designation | 2025-07-21 | Investing News - Stockhouse

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences Soars 134%—What’s Fueling This Biotech Breakout? - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences (PMN) up more than 300% since Jul 8 - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Promis Neurosciences shares surge 250% intraday after FDA grants Fast Track designation for PMN310 Alzheimer's treatment. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences: Stock Surge Insight - StocksToTrade

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences Soars 157% on FDA Fast Track Designation – What’s Fueling This Volatile Rally? - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences stock soars after FDA grants Fast Track for Alzheimer’s drug - Investing.com

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences Surges: Analyzing Recent Moves - timothysykes.com

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences shares surge 21.37% premarket after FDA grants Fast Track designation to PMN310 for Alzheimer’s treatment. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences stock price surges in pre market trading as company receives FDA fast track designation for alzheimer’s drug candidate PMN310 - MSN

Jul 21, 2025
pulisher
Jul 21, 2025

Why Is ProMIS Neurosciences Stock (PMN) Up 180% Today? - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences shares surge 17.50% premarket after FDA grants Fast Track designation to PMN310 for Alzheimer’s treatment. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Why ProMIS Is Rising In Pre-market? - Nasdaq

Jul 21, 2025
pulisher
Jul 21, 2025

FDA grants fast track designation to ProMIS Neurosciences’ Alzheimer’s drug By Investing.com - Investing.com South Africa

Jul 21, 2025
pulisher
Jul 21, 2025

FDA grants fast track designation to ProMIS Neurosciences’ Alzheimer’s drug - Investing.com Australia

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences granted Fast Track designation by FDA for PMN310 - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences Granted Fast Track Designation by U.S. - GlobeNewswire

Jul 21, 2025
pulisher
Jul 21, 2025

FDA Fast-Tracks Revolutionary Alzheimer's Drug Promising Fewer Side Effects Than Current Treatments - Stock Titan

Jul 21, 2025

Promis Neurosciences Inc (PMN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$23.59
price up icon 3.15%
$36.58
price up icon 1.43%
$103.34
price down icon 0.13%
$27.52
price down icon 2.23%
$113.95
price down icon 0.57%
biotechnology ONC
$295.88
price up icon 0.25%
자본화:     |  볼륨(24시간):